A Study of Docetaxel for Injection (Albumin-bound) and SG001 in Combination With Cisplatin and Simultaneous Radiotherapy for Locally Advanced Unresectable Esophageal Squamous Carcinoma.
Clinical trial NCT06136988 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06136988
- Sponsor
- CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-01
- Primary completion
- 2027-04-01
- Enrollment
- 129
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.